ONCY oncolyticsbiotech.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

Tandha merek Oncolytics Biotech Inc. (ONCY)

This trading chart helps assess the business value of Oncolytics Biotech Inc. (ONCY), where the EV/EBITDA multiple stands at 0.00. Oncolytics Biotech Inc. (ONCY) leverages significant pricing power driven by its unique reovirus that selectively targets tumors. Management is focused on implementing innovative therapy standards and securing partners. An extensive patent portfolio and global alliances protect the developer from competitive pricing pressure.

ONCY Oncolytics Biotech, Inc.: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 12.11.2026

Rincian metrik lan analitis perusahaan oncolyticsbiotech.com (ONCY)

- rega saham lan target rega konsensus:
Kutipan saham Oncolytics Biotech|ONCY - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Biji pasar Oncolytics Biotech Inc.|ONCY - Nilai Dipunlarasaken Utang lan Kas
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham Oncolytics Biotech|ONCY - Nilai Aset Bersih|Rasio Nilai Pasar marang Nilai Buku oncolyticsbiotech.com|ONCY - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Oncolytics Biotech Inc.|ONCY - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Oncolytics Biotech|ONCY - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Oncolytics Biotech Inc.|ONCY - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Oncolytics Biotech|Likuiditas cepet oncolyticsbiotech.com
- data bathi bisnis lan rasio investasi:
ONCY - Bathi pungkasan|Bathi sing dikarepake Oncolytics Biotech Inc.|ONCY - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Oncolytics Biotech|ONCY - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Oncolytics Biotech Inc.|ONCY - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Oncolytics Biotech|ONCY - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan oncolyticsbiotech.com|ONCY - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oncolytics Biotech Inc.
Analisis umum perusahaan:Oncolytics ONCY
Sampel barang Oncolytics Biotech, Inc.

The operational efficiency of Oncolytics Biotech Inc. (ONCY) is reflected in its current EV/EBITDA multiple. This indicator compares the total enterprise value, including net debt, with earnings before interest, taxes, depreciation, and amortization. This methodology allows for an assessment of the real value of assets, stripped of the influence of financial leverage. For a biotechnology company with strong patent protection, this ratio confirms the investment attractiveness of its fundamental base.

Pesaing langsung

Geron Corp. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nanobiotix Group (NBTX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|BCYC: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan CTMX (cytomx.com)|perspectivetherapeutics.com (CATX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan GNLX (Genelux)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Molecular Partners AG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LSTA|Pangali EV/EBITDA MBRX|Pangali EV/EBITDA galeratx.com (GRTX)|Molecular Templates, Inc. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan